Teva Pharma (TEVA) Announces Positive Variation Procedure Outcome for COPAXONE European Label
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced that it has received a positive outcome through the variation procedure to remove ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
